Beck Bode LLC’s Accendra Health ACH Stock Holding History

Beck Bode LLC’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-314,361	Closed	-$13.3M	–	232
2021 Q2	$13.3M	Buy	314,361 +7,343	+2%	+$286K	3.67%	5
2021 Q1	$11.5M	Buy	+307,018	New	+$9.6M	3.55%	13

Other funds holding ACH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Beck Bode LLC's ACH Position: Q3 2021 in Review

Beck Bode LLC sold out of Accendra Health (ACH) in Q3 2021, closing a stake of 314,361 shares — an estimated $13.3M sold.

Beck Bode LLC first reported a position in ACH in Q1 2021 and held it in 2 quarters. The position peaked at $13.3M in Q2 2021. 247 funds tracked by Wall St. Rank hold ACH as of Q3 2021.

Beck Bode LLC reported no remaining Accendra Health position as of Q3 2021 after selling out during the quarter.
Beck Bode LLC sold 314,361 Accendra Health shares in Q3 2021, an estimated $13.3M.
Beck Bode LLC first reported a position in Accendra Health in Q1 2021 and held it in 2 quarters.
Beck Bode LLC's Accendra Health position peaked at $13.3M in Q2 2021.
247 funds tracked by Wall St. Rank held Accendra Health as of Q3 2021.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.